Bisphosphonate treatment ( DrugBank: - )

2 diseases

ID	Disease name (Link within this page)	Number of trials
113	Muscular dystrophy	1
299	Cystic fibrosis	1

113. Muscular dystrophy

Clinical trials : 646 / Drugs : 471 - (DrugBank : 105) / Drug target genes : 59 - Drug target pathways : 170

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01882400 (ClinicalTrials.gov)	May 2001	17/6/2013	Assessment of Response to Treatment of Osteoporosis With Oral Bisphosphonates in Patients With Muscular Dystrophy	Évaluation Multidimensionnelle de la réponse au Traitement de l'ostéoporose spontanée et Induite Par Les corticostéroïdes à l'Aide d'un Bisphosphonate à Administration Orale Chez Des Malades Porteurs d'Une Dystrophie Musculaire sévère.	Osteoporosis;Muscular Dystrophy;Cystic Fibrosis	Drug: Bisphosphonate treatment	Gilles Boire	Procter and Gamble	Completed	5 Years	18 Years	All	11	Phase 4	Canada

Clinical trials : 1,695 / Drugs : 1,527 - (DrugBank : 268) / Drug target genes : 111 - Drug target pathways : 174

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01882400 (ClinicalTrials.gov)	May 2001	17/6/2013	Assessment of Response to Treatment of Osteoporosis With Oral Bisphosphonates in Patients With Muscular Dystrophy	Évaluation Multidimensionnelle de la réponse au Traitement de l'ostéoporose spontanée et Induite Par Les corticostéroïdes à l'Aide d'un Bisphosphonate à Administration Orale Chez Des Malades Porteurs d'Une Dystrophie Musculaire sévère.	Osteoporosis;Muscular Dystrophy;Cystic Fibrosis	Drug: Bisphosphonate treatment	Gilles Boire	Procter and Gamble	Completed	5 Years	18 Years	All	11	Phase 4	Canada